The U.S. consumer market for cannabinoid pharmaceuticals is projected to exceed $50 billion by 2029, according to Statista. The market has gained … Read More
The post GW Pharmaceuticals Targets Long-Term Profits With Epidiolex appeared first on Dagga Magazine.